Vascular Access Complication
Conditions
Keywords
central venous access device, catheter-related complications, venous thromboembolism, catheter-related bloodstream infection, peripherally inserted central catheters, home parenteral nutrition
Brief summary
Central vascular access devices are required for home parenteral nutrition (HPN). There is few data available concerning their complications in adult HPN patients, and the potential link between venous thromboembolism and catheter infection is not well established. The aim of this prospective cohort study is to compare the incidence rate of catheter related complications among 3 types of central vascular access: peripherally inserted central catheters; tunneled catheters and port-a-cath devices, in adults patients on HPN; describe the risk factors, and identify a potential link between venous thromboembolism and infection. More than 300 patients will be consecutively enrolled and followed up from the time of catheter insertion until its removal. Venous complication (identify by an ultrasound examination if deep vein thrombosis is suspected), infection related to catheter and mechanical complications will be analyzed. The incidence of complications will be expressed per 1000 catheters-day and or as a percentage of total catheter.
Interventions
OTHERThe complications related to central venous access device
The complications related to central venous access device were collected when occurs : from time of catheter insertion, until first complication, or removal for another type of catheter, or until death.
Sponsors
Hospices Civils de Lyon
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* adult patients * having a catheter insertion during the study periode * at the unit of vascular access of Lyon Sud Hospital * for parenteral nutrition * from July 1st, 2017 to June 30, 2020
Exclusion criteria
* catheter inserted in intensive care unit * for other treatment (chemotherapy, antibiotic)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rate of (incidence) symptomatic venous thromboembolism, catheter related infection, and mechanical complications related to central venous access device | From date of randomization until the date of first documented progression or date of death from any cause, whichever came first, assessed up to 36 months | * Deep vein thrombosis of the upper extremity : suspected if symptomatic (swelling, local pain, edema) and confirmed by venous ultrasound and/or computed tomography * Catheter related bloodstream infection suspected if local inflammation and/or fever, and confirmed by blood sample and/or catheter culture * Mechanical complications (displacement, drop, kink) : described by nurses or patient |
Countries
France
Outcome results
None listed